Dr. Adam Ehrlich Shares His Expertise on Biologic Medications Used to Treat Crohn’s Disease

Adam C. Ehrlich, MD, MPH, Associate Professor of Medicine at the Lewis Katz School of Medicine at Temple University, Co-Medical Director of the Inflammatory Bowel Disease Program at Temple University Hospital (TUH), and Program Director of the Gastroenterology Fellowship at TUH, offered insight to HealthCentral on biologic drugs used to treat Crohn’s disease. Dr. Ehrlich provided advice for patients who may receive the treatment, which is available via infusion or injection.